Innate immunity and pathology of the critical patient
PRINCIPAL INVESTIGATORS
- Joan Sabater Riera
CLINICAL RESEARCHERS
- Luisa Corral Ansa
- Maria Paz Fuset Cabanes
- Arnau Ulsamer Riera
- Francesc Esteve Urbano
- Eva Oliver Juan
- Xosé Luis Pérez Fernández
- Gabriel Jesus Moreno González
- Ana Rosa Ochagavía Calvo
POSTDOCTORAL RESEARCHERS
- Sara Olivera Ardid
PREDOCTORAL RESEARCHERS
- Ricard Soley Corderas
- Victor Daniel Gumucio Sanguino
SCIENTIFIC SUPPORT
- Africa Talib i Montsech
Translational Medicine
Infectious disease and transplantation
Scientific production
19
PAPERS
Average IF: 8,11
9
LED PAPERS
Average IF: 11,99
4 PUBLICATIONS IN FIRST DECILE
8 PUBLICATIONS IN FIRST QUARTILE
6 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Pérez Fernández,X;Ulsamer,A;Cámara Rosell,M;Sbraga,F;Boza Hernández,E;Moret Ruíz,E;Plata Menchaca,E et al, Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery: The SIRAKI02 Randomized Clinical Trial., JAMA, 2024;332(17):1446-1454, doi:10.1001/jama.2024.20630
- Paniagua García,M;Bravo Ferrer,JM;Pérez Galera,S;Kostyanev,T;de Kraker,M;Feifel,J;Palacios Baena,ZR et al, Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA), Clin. Microbiol. Infect., 2024;30(2):223-230, doi:10.1016/j.cmi.2023.11.008
- Ceccato,A;Forne,C;Bos,LD;Camprubi Rimblas,M;Areny Balaguero,A;Campana Duel,E;Quero,S et al, Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort, Crit. Care, 2024;28(1):doi:10.1186/s13054-024-04876-5
- Guimbretière,G;Sénage,T;Boureau,AS;Roos,JC;Bernard,Q;Carlier,B;Veziers,J et al, Calcification of surgical aortic bioprostheses and its impact on clinical outcome, Eur. Heart J.-Cardiovasc. Imaging, 2024;25(9):1226-1234, doi:10.1093/ehjci/jeae100
- Hernández Jiménez,E;Plata Menchaca,EP;Berbel,D;de Egea,GL;Dastis Arias,M;García Tejada,L;Sbraga,F et al, Assessing sepsis-induced immunosuppression to predict positive blood cultures, Front. Immunol., 2024;151447523-1447523, doi:10.3389/fimmu.2024.1447523
Research highlights
PROJECTS
1 Ongoing competitive project
PUBLISHED WORKS
1 Clinical guideline
INNOVATION
1 Patent
2 Licenses
1 spin-off
Selected projects
- 101045956. COVend: Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19. COMISSIÓ EUROPEA. Budget: 114.101,66€. 2021-2024. PI: Máñez Mendiluce, Rafael.